Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 02, 2024 08:30 ET
YY Group Announces Strategic Entry Into Vietnam’s Booming Labour Market Within the Dynamic Hospitality Industry
YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”), a data and technology-driven company that specializes in creating enterprise intelligent labor matching services and smart cleaning solutions, is pleased to announce...
May 02, 2024 08:29 ET
Dremio Announces Expansive Deployment Options to Accelerate Analytics and AI with the Leading Iceberg Lakehouse
Dremio, the unified lakehouse platform for self-service analytics and AI, announced new capabilities that ensure its market leading Apache Iceberg lakehouse is the most flexible, fast, and easy-to-use for every data environment. At its flagship...
May 02, 2024 08:08 ET
Conqueror Freight Network brings together more than 120 logistics leaders from all over the world in Bali to celebrate its 10th Annual Meeting
Conqueror seized this special anniversary as an opportunity to recognize founding members with an Awards Ceremony and to present its new web app, its new website and cutting-edge digital services Bali, 2nd May 2024: Conqueror’s networking and...
May 02, 2024 08:05 ET
STACKIT and Dremio Pioneer Data Sovereignty and Accelerate AI Innovation
Dremio, the unified lakehouse platform for self-service analytics and AI, and STACKIT, the premier data-sovereign cloud provider in Europe and part of the IT organization within Schwarz Group, today announced a strategic partnership that provides...
May 02, 2024 08:04 ET
Capital gains tax hike will hurt investment and entrepreneurship, says MEI
Raising the capital gains inclusion rate will deter venture capital investment and entrepreneurship in Canada, asserts the Montreal Economic Institute in a study released this morning. “If the Trudeau and Legault governments are looking to chase...
May 02, 2024 08:03 ET
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will report first quarter 2024 financial results and provide a business update on Tuesday, May 14, 2024 after the U.S....
May 02, 2024 08:01 ET
STALICLA initiates U.S. Phase 3 enabling DDI study of STP7 (Mavoglurant) to treat cocaine use disorder
Geneva, Switzerland, May 2, 2024 – STALICLA SA, a late-stage biotechnology company specializing in precision medicine for brain disorders, announces the First Patient First Visit (FPFV) for the company's drug-drug interaction (DDI) study of STP7...
May 02, 2024 08:00 ET
Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024
Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it...
May 02, 2024 08:00 ET
Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer
Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics for cancer and genetic disorders, today announced the appointment of Adam Hughes, Ph.D., as Chief...
May 02, 2024 08:00 ET
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today...
May 02, 2024 08:00 ET
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing molecular diagnostic solutions in China, have jointly announced that KR-HT5, which Akoya Biosciences co-developed with...
May 02, 2024 08:00 ET
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early discontinuation of its Phase 2...
May 02, 2024 08:00 ET
Alterra IOS Venture III raises $925 million, surpassing $750 million target and increasing hard cap beyond $850 million
Philadelphia-based Alterra Property Group, LLC (“Alterra”) and New York-based Park Madison Partners today announced the final close of Alterra IOS Venture III, LP (“Venture III”). Venture III was oversubscribed with $925MM of total commitments,...
May 02, 2024 08:00 ET
Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism
Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that eneboparatide, its lead therapeutic peptide candidate in Phase 3 development for the treatment of...
May 02, 2024 08:00 ET
Aqua Security Releases Industry-First Solution to Secure Large Language Model (LLM)-Based Applications from Code to Cloud
Aqua Security, the pioneer in cloud native security, today unveiled new capabilities specifically designed to secure the development and operation of generative AI applications leveraging Large Language Models (LLMs). As more and more businesses...
May 02, 2024 08:00 ET
Arbe to Participate at the Oppenheimer 9th Annual Emerging Growth Conference
Tel Aviv, Israel, May 2, 2024— Arbe Robotics Ltd. (Nasdaq: ARBE) (“Arbe”), a global leader in Perception Radar solutions, today announced that Kobi Marenko, Chief Executive Officer, and Karine Pinto-Flomenboim, Chief Financial Officer, participate...
May 02, 2024 08:00 ET
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver nine presentations offering insights into its adeno-associated virus (AAV) research and...
May 02, 2024 08:00 ET
Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch
Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the formal launch of an updated OvaWatch ovarian...
May 02, 2024 08:00 ET
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm
Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence (AI) technology company specializing in the development of advanced AI and data center infrastructure solutions, has named William Hisey as the Company’s...
May 02, 2024 08:00 ET
Bebuzee’s Revolutionary Super App Will Disrupt US and European Markets
via IBN – Bebuzee, Inc. (OTC PINK: BBUZ) a social platform and streaming service focused on developing and deploying America's first Super App, today announces the launch of its game-changing Super App, set to redefine the digital landscape in the...